Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary

Surface Oncology

02/08/2023 14:11

* Surface Oncology Inc  SURF.OQ  reported a quarterly
adjusted
loss of 46 cents​​ per share for the quarter ended in June. The
mean expectation of five analysts for the quarter was for a loss
of 34 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Surface Oncology Inc's reported EPS for the quarter was a
loss
of 46 cents​.
    * The mean earnings estimate of analysts had risen by
about 4.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Surface Oncology Inc shares had risen by 8.7% this
quarter and
gained 15.2% so far this year.
    * The company reported a quarterly loss of $28.19 million.
    * Wall Street's median 12-month price target for Surface
Oncology
Inc is $1.15 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 2 at 01:10 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.34          -0.46          Missed
 Mar. 31 2023      -0.36          -0.33          Beat
 Dec. 31 2022      -0.33          -0.35          Missed
 Sep. 30 2022      -0.47          -0.39          Beat